Insider Transactions in Q2 2021 at Outset Medical, Inc. (OM)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-55.16%
|
$836,350
$50.72 P/Share
|
|
Jun 24
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
Jun 22
2021
|
Jean Olivier Racine Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,879
+50.0%
|
-
|
|
Jun 17
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,445
-8.97%
|
$72,250
$50.0 P/Share
|
|
Jun 17
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,445
+8.23%
|
$13,005
$9.48 P/Share
|
|
Jun 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$164,500
$47.87 P/Share
|
|
Jun 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Jun 03
2021
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+28.3%
|
-
|
|
Jun 03
2021
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+50.0%
|
-
|
|
Jun 03
2021
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+24.68%
|
-
|
|
Jun 03
2021
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+27.49%
|
-
|
|
Jun 03
2021
|
Patrick T Hackett Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+50.0%
|
-
|
|
Jun 03
2021
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+12.37%
|
-
|
|
Jun 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-7.39%
|
$940,000
$47.9 P/Share
|
|
Jun 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.88%
|
$20,000
$1.11 P/Share
|
|
Jun 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-35.08%
|
$235,000
$47.91 P/Share
|
|
Jun 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.97%
|
$15,000
$3.88 P/Share
|
|
Jun 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-100.0%
|
$60,912
$47.92 P/Share
|
|
Jun 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+50.0%
|
$1,296
$1.11 P/Share
|
|
May 25
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-55.16%
|
$752,715
$45.11 P/Share
|
|
May 25
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
May 20
2021
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,747
+46.0%
|
-
|
|
May 17
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$147,000
$42.34 P/Share
|
|
May 17
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
May 03
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
2,592
-73.06%
|
$150,336
$58.72 P/Share
|
|
May 03
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,592
+50.0%
|
$2,592
$1.11 P/Share
|
|
May 03
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-12.5%
|
$290,000
$58.84 P/Share
|
|
May 03
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.03%
|
$15,000
$3.88 P/Share
|
|
May 03
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-2.5%
|
$1,160,000
$58.79 P/Share
|
|
May 03
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.88%
|
$20,000
$1.11 P/Share
|
|
Apr 27
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-32.86%
|
$936,712
$56.61 P/Share
|
|
Apr 27
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
Apr 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-9.75%
|
$189,000
$54.55 P/Share
|
|
Apr 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Apr 13
2021
|
Warburg Pincus X, L.P. |
SELL
Open market or private sale
|
Indirect |
3,890,723
-82.22%
|
$194,536,150
$50.83 P/Share
|
|
Apr 13
2021
|
Warburg Pincus LLC |
SELL
Open market or private sale
|
Indirect |
3,890,723
-82.22%
|
$194,536,150
$50.83 P/Share
|
|
Apr 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
2,592
-100.0%
|
$142,560
$55.06 P/Share
|
|
Apr 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,592
+50.0%
|
$2,592
$1.11 P/Share
|
|
Apr 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
57,500
-9.81%
|
$3,162,500
$55.37 P/Share
|
|
Apr 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
57,500
+6.2%
|
$57,500
$1.11 P/Share
|
|
Apr 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
22,500
-42.13%
|
$1,237,500
$55.18 P/Share
|
|
Apr 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+30.11%
|
$67,500
$3.88 P/Share
|